Lakewood-Amedex Biotherapeutics, Inc. (LABT)
0.2359
-0.05
(-17.23%)
USD |
NASDAQ |
Oct 29, 16:00
0.2248
-0.01
(-4.71%)
After-Hours: 19:03
Lakewood-Amedex Biotherapeutics Market Cap : 0.5117M for Oct. 29, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 28, 2026 | 0.6182M |
| October 27, 2026 | 0.6208M |
| October 26, 2026 | 0.6139M |
| October 23, 2026 | 0.6725M |
| October 22, 2026 | 1.062M |
| October 21, 2026 | 1.011M |
| October 20, 2026 | 1.253M |
| October 19, 2026 | 1.266M |
| October 16, 2026 | 1.258M |
| October 15, 2026 | 1.328M |
| October 14, 2026 | 1.370M |
| October 13, 2026 | 1.505M |
| October 12, 2026 | 1.586M |
| October 09, 2026 | 1.697M |
| October 08, 2026 | 1.718M |
| October 07, 2026 | 1.843M |
| October 06, 2026 | 1.881M |
| October 05, 2026 | 1.854M |
| October 02, 2026 | 2.023M |
| October 01, 2026 | 2.018M |
| September 30, 2026 | 2.072M |
| September 29, 2026 | 2.147M |
| September 28, 2026 | 2.495M |
| September 25, 2026 | 3.623M |
| September 24, 2026 | 3.959M |
| Date | Value |
|---|---|
| September 23, 2026 | 3.861M |
| September 22, 2026 | 4.317M |
| September 21, 2026 | 4.447M |
| September 18, 2026 | 4.317M |
| September 17, 2026 | 4.035M |
| September 16, 2026 | 4.534M |
| September 15, 2026 | 4.707M |
| September 14, 2026 | 4.599M |
| September 11, 2026 | 4.816M |
| September 10, 2026 | 4.447M |
| September 09, 2026 | 5.032M |
| September 08, 2026 | 4.729M |
| September 04, 2026 | 4.078M |
| September 03, 2026 | 4.122M |
| September 02, 2026 | 4.490M |
| September 01, 2026 | 5.987M |
| August 31, 2026 | 5.423M |
| August 28, 2026 | 4.989M |
| August 27, 2026 | 5.401M |
| August 26, 2026 | 5.314M |
| August 25, 2026 | 4.968M |
| August 24, 2026 | 4.620M |
| August 21, 2026 | 4.859M |
| August 20, 2026 | 4.750M |
| August 19, 2026 | 4.859M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 8.537B |
| Oncolytics Biotech, Inc. | 53.26M |
| Sangamo Therapeutics, Inc. | 48.88M |
| Sarepta Therapeutics, Inc. | 2.031B |
| Anixa Biosciences, Inc. | 114.82M |
Market Cap Related Metrics
| PEG Ratio | -0.0002 |
| Price to Book Value | 0.1181 |
| Price | 0.2359 |
| Earnings Yield | -4.38K% |
| PEGY Ratio | -0.0002 |